Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion
Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) announced Tuesday that it has received final acceptance from the TSX Venture Exchange for its previously announced acquisition of a Canadian licensed producer of cannabis, AgMedica Bioscience Inc.
The acquisition, arranged through an agreement with Callisto Capital Corp. on October 28, 2024, was made in exchange for a $6.3 million unsecured convertible debenture. As a result of receiving the acceptance, Decibel has completed the conversion of the convertible debenture, pursuant to which it has issued 114.55 million common shares to Callisto.
The conversion of the convertible debenture was conditional upon receipt of final TSXV acceptance for the acquisition of AgMedica pursuant to Exchange Policy 5.3. This policy would have required approval from …